RRM2 and acute myeloid leukemia: In the present study, the expression of RNR subunits, especially RRM2, was strongly correlated with malignant proliferation in a large cohort of patients with AML in the GEO and TCGA databases, suggesting a rationale for inhibiting RNR to treat AML.